Quoin Pharmaceuticals Ltd DRC

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$5.01-$37.80
Market Cap
$3.8M
Shares Short
12,505

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$66.85

News

See more

Yahoo Finance • 20 days ago

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

Yahoo Finance • 28 days ago

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient

Yahoo Finance • last month

Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

Yahoo Finance • 2 months ago

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study

About

CEO
Dr. Michael Myers Ph.D.
Address
42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
3